Studie-index
0-9 | A | B |C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Studie
A to Z
Aggrastat to Zocor Study
eptifibatide, simvastatine
MSD, MSD
ABCD
Appropriate Blood pressure Control in Diabetes
nisoldipine
AstraZeneca
ACAPS
Asymptomatic Carotid Artery Plaque Study
ACAS
Asymptomatic Carotid Atherosclerosis Study
ACCORD
Angioplastie Coronaire, CORvasal and Diltiazem
diltiazem
Lorex
ACCT
Amlodipine Cardiovascular Community Trial
amlodipine
Pfizer
ACIP
Asymptomatic Cardiac Ischemia Pilot study
ACME
Angioplasty Compared to Medicine
heparine
Generiek
ACUITY
The Acute Catheterization and Intervention Triage Strategy
bivalirudine
Nycomed Nederland B.V.
ADEG
Antiarrhythmic Drug Evaluation Group
flecaïnide, propafenon, amiodaron
3M Pharma, Knoll, Sanofi
ADVANCE
Action in Diabetes and Vascular disease PreterAx and DiamicroN MR Controlled Evaluation
perindopril, indapamide
Servier, Servier
AFASAK
Copenhagen Atrial Fibrillation, Aspirin and Anticoagulation
aspirine
Generiek
AFCAPS / TEXCAPS
Air Force/Texas Coronary Atherosclerosis Prevention Study
AFTER
Aspirin/Anticoagulants Following Thrombolysis with anistreplase (Eminase) in Recurrent infarction
anistreplase, aspirine, heparine
SKB, Generiek, Generiek
AIMS
APSAC Intervention Mortality Study
streptokinase
Aventis
AIRE
Acute Infarction Ramipril Efficacy study
ramipril
Aventis
AIREX
AIRE Extension study
ramipril
Aventis
ALLHAT
Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial
chloortalidon, amlodipine , lisinopril, pravastatine, doxazosine
Novartis, Pfizer, AstraZeneca, Bristol-Myers Squibb, Pfizer
AMADEO
A comparison of telMisartan versus losArtan in hypertensive type 2 DiabEtics patients with Overt nephropathy
telmisartan
Boehringer Ingelheim
AMICUS
Austrian Multicenter Isradipine Cum Spirapril study
isradipine
Novartis
ANBP2
Australian National Blood Pressure study 2
APIS
Antihypertensive Patch Italian Study
APRICOT
Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis
heparine
Generiek
APSI
Acebutolol et Prévention Secondaire de l’lnfarctus
acebutolol
Rhone-Poulenc Rorer
APSIS
Angina Prognosis Study In Stockholm
metoprolol, verapamil
AstraZeneca, Knoll
APTH
Ambulatory blood Pressure and Treatment of Hypertension
lisinopril, hydrochloorthiazide, amlodipine
AstraZeneca, Novartis, Pfizer
ARIC
Atherosclerosis Risk In Communities
ARMS
APSAC Reocclusion Multicentre Study
anistreplase
SKB
ART
ASAAC
Acetylsalicylic Acid versus Anticoagulants study
aspirine, heparine, fenprocoumon
Generiek, Generiek, Roche
ASCB
Asymptomatic Cervical Bruit
ASCOT
Anglo Scandinavian Cardiac Outcome Trial
atenolol, bendroflumethiazide, amlodipine , perindopril
AstraZeneca, Leo, Pfizer, Servier
ASIST
Atenolol Silent Ischemia Study
atenolol
AstraZeneca
ASK
Australian Streptokinase Trial
streptokinase
Aventis
ASPECT
Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis
acenocoumarol, fenprocoumon
Novartis, Roche
ASPIRE
Action on Secondary Prevention through Intervention to Reduce Events
ASSENT-2
Assessment of the Safety and Efficacy of a New Thrombolytic - 2
tenecteplase, alteplase
Boehringer Ingelheim, Boehringer Ingelheim
ASSENT-3
ASsessment of the Safety and Efficacy of New Thrombolytic regimens
tenecteplase
Boehringer Ingelheim
ASSET
Anglo-Scandinavian Study of Early Thrombolysis
ATACS
Antithrombotic Therapy in Acute Coronary Syndromes
heparine
Generiek
ATLAS
Assessment of Treatment with Lisinopril And Survival
lisinopril
AstraZeneca
ATLAS 2
Rivaroxaban (Xarelto) in Patients with a Recent Acute Coronary Syndrome
rivaroxaban
Bayer Health Care B.V.
AVID
Antiarrhythmics Versus Implantable Defibrillators
amiodaron, sotalol
Sanofi, Bristol-Myers Squibb